Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHAMINDRA G LAVERTY

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1538320395
CMS profile
577703
Location
SAN DIEGO, CA

General Payments · PY2018–2024

$488,359.37

  • Reported across 303 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$198,423.11

52 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Sarepta Therapeutics, Inc. $163,363.64 30
Biogen, Inc. $12,381.25 11
PTC Therapeutics, Inc. $9,200.00 1
UCB SA $4,680.00 1
ITF Therapeutics LLC $4,125.00 2
CATALYST PHARMACEUTICALS, INC. $2,400.00 1
PFIZER INC. $2,114.06 2
Genentech, Inc. $90.50 1
NOVARTIS PHARMACEUTICALS CORPORATION $27.24 1
UCB, Inc. $24.67 1
Neurelis, Inc. $16.75 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $11,828.35 22
PY2019 $43,381.74 56
PY2020 $24,933.16 25
PY2021 $35,433.75 21
PY2022 $74,144.02 53
PY2023 $100,215.24 74
PY2024 $198,423.11 52

Payment records · PY2024 (52)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Biogen, Inc. $2,690.00 03/03/2024 Consulting Fee Undisputed 01/23/2026 1104821984 CMS
Biogen, Inc. $3,228.00 03/04/2024 Consulting Fee Undisputed 01/23/2026 1104831098 CMS
Biogen, Inc. $31.00 10/13/2024 Travel and Lodging Undisputed 01/23/2026 1104873696 CMS
Biogen, Inc. $6.00 10/14/2024 Food and Beverage Undisputed 01/23/2026 1104806187 CMS
Biogen, Inc. $38.00 10/14/2024 Food and Beverage Undisputed 01/23/2026 1104818596 CMS
Biogen, Inc. $34.00 10/14/2024 Travel and Lodging Undisputed 01/23/2026 1104841930 CMS
Biogen, Inc. $45.00 10/14/2024 Travel and Lodging Undisputed 01/23/2026 1104858788 CMS
Biogen, Inc. $1,293.00 10/14/2024 Travel and Lodging Undisputed 01/23/2026 1104869118 CMS
Biogen, Inc. $8.00 10/14/2024 Food and Beverage Undisputed 01/23/2026 1104874606 CMS
Biogen, Inc. $2,378.00 11/26/2024 Consulting Fee Undisputed 01/23/2026 1104821986 CMS
Biogen, Inc. $2,630.25 12/18/2024 Consulting Fee Undisputed 01/23/2026 1104808647 CMS
CATALYST PHARMACEUTICALS, INC. $2,400.00 04/02/2024 Consulting Fee Undisputed 01/23/2026 1144451773 CMS
Genentech, Inc. $90.50 06/06/2024 Food and Beverage Undisputed 01/23/2026 1132985829 CMS
ITF Therapeutics LLC $1,200.00 12/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1082127331 CMS
ITF Therapeutics LLC $2,925.00 12/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1082127333 CMS
Neurelis, Inc. $16.75 12/01/2024 Food and Beverage Undisputed 01/23/2026 1145645635 CMS
Novartis Pharmaceuticals Corporation $27.24 07/24/2024 Food and Beverage Undisputed 01/23/2026 1087130878 CMS
PFIZER INC. $114.06 03/03/2024 Food and Beverage Undisputed 01/23/2026 1131240038 CMS
PFIZER INC. $2,000.00 04/02/2024 Consulting Fee Undisputed 01/23/2026 1131586568 CMS
PTC Therapeutics, Inc. $9,200.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 1152941510 CMS
Sarepta Therapeutics, Inc. $17,050.00 01/04/2024 Consulting Fee Undisputed 01/23/2026 1126541155 CMS
Sarepta Therapeutics, Inc. $550.00 01/04/2024 Consulting Fee Undisputed 01/23/2026 1126541181 CMS
Sarepta Therapeutics, Inc. $50.00 03/02/2024 Food and Beverage Undisputed 01/23/2026 1126541167 CMS
Sarepta Therapeutics, Inc. $50.00 03/02/2024 Food and Beverage Undisputed 01/23/2026 1126541169 CMS
Sarepta Therapeutics, Inc. $100.06 03/02/2024 Food and Beverage Undisputed 01/23/2026 1126541173 CMS
Sarepta Therapeutics, Inc. $251.00 03/02/2024 Travel and Lodging Undisputed 01/23/2026 1126541175 CMS
Sarepta Therapeutics, Inc. $429.19 03/02/2024 Travel and Lodging Undisputed 01/23/2026 1126541179 CMS
Sarepta Therapeutics, Inc. $565.86 03/02/2024 Travel and Lodging Undisputed 01/23/2026 1126541183 CMS
Sarepta Therapeutics, Inc. $11,640.00 03/28/2024 Consulting Fee Undisputed 01/23/2026 1126541147 CMS
Sarepta Therapeutics, Inc. $77.59 04/18/2024 Travel and Lodging Undisputed 01/23/2026 1126541171 CMS
Sarepta Therapeutics, Inc. $1,100.00 04/19/2024 Consulting Fee Undisputed 01/23/2026 1126541133 CMS
Sarepta Therapeutics, Inc. $1,650.00 04/24/2024 Consulting Fee Undisputed 01/23/2026 1126541137 CMS
Sarepta Therapeutics, Inc. $3,990.00 05/13/2024 Consulting Fee Undisputed 01/23/2026 1126541141 CMS
Sarepta Therapeutics, Inc. $3,990.00 05/30/2024 Consulting Fee Undisputed 01/23/2026 1126541143 CMS
Sarepta Therapeutics, Inc. $1,215.00 07/15/2024 Consulting Fee Undisputed 01/23/2026 1126541135 CMS
Sarepta Therapeutics, Inc. $34,720.00 07/15/2024 Consulting Fee Undisputed 01/23/2026 1126541159 CMS
Sarepta Therapeutics, Inc. $32,450.00 07/17/2024 Consulting Fee Undisputed 01/23/2026 1126541157 CMS
Sarepta Therapeutics, Inc. $2,660.00 08/22/2024 Consulting Fee Undisputed 01/23/2026 1126541139 CMS
Sarepta Therapeutics, Inc. $831.25 10/24/2024 Consulting Fee Undisputed 01/23/2026 1126541131 CMS
Sarepta Therapeutics, Inc. $10,307.50 10/24/2024 Consulting Fee Undisputed 01/23/2026 1126541145 CMS
Sarepta Therapeutics, Inc. $12,468.75 10/24/2024 Consulting Fee Undisputed 01/23/2026 1126541151 CMS
Sarepta Therapeutics, Inc. $13,133.75 10/24/2024 Consulting Fee Undisputed 01/23/2026 1126541153 CMS
Sarepta Therapeutics, Inc. $665.00 10/24/2024 Consulting Fee Undisputed 01/23/2026 1126541187 CMS
Sarepta Therapeutics, Inc. $665.00 10/24/2024 Consulting Fee Undisputed 01/23/2026 1126541189 CMS
Sarepta Therapeutics, Inc. $11,640.00 10/31/2024 Consulting Fee Undisputed 01/23/2026 1126541149 CMS
Sarepta Therapeutics, Inc. $21.89 10/31/2024 Food and Beverage Undisputed 01/23/2026 1126541161 CMS
Sarepta Therapeutics, Inc. $43.67 10/31/2024 Food and Beverage Undisputed 01/23/2026 1126541163 CMS
Sarepta Therapeutics, Inc. $43.67 10/31/2024 Food and Beverage Undisputed 01/23/2026 1126541165 CMS
Sarepta Therapeutics, Inc. $400.00 10/31/2024 Travel and Lodging Undisputed 01/23/2026 1126541177 CMS
Sarepta Therapeutics, Inc. $604.46 10/31/2024 Travel and Lodging Undisputed 01/23/2026 1126541185 CMS
UCB SA $4,680.00 03/22/2024 Consulting Fee Undisputed 01/23/2026 1113951499 CMS
UCB, Inc. $24.67 03/22/2024 Food and Beverage Undisputed 01/23/2026 1143086430 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.